A pilot study on use of live attenuated rotavirus vaccine (Rotarix™) as an infection challenge model. (2020)
Attributed to:
Human live-attenuated rotavirus to assess next-genchallenge with eration rotavirus vaccines in Africa
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.vaccine.2020.09.023
PubMed Identifier: 33032844
Publication URI: http://europepmc.org/abstract/MED/33032844
Type: Journal Article/Review
Volume: 38
Parent Publication: Vaccine
Issue: 46
ISSN: 0264-410X